Hopes of finding a treatment for the deadly Ebola virus shifted on Monday to a small California-based biotech company whose experimental drug has been used to treat two American missionary workers. The drug, developed by Mapp Biopharmaceutical Inc, was used to treat two aid workers, one from the Samaritan's Purse group and the other from Christian mission group SIM USA, who were exposed to the disease in Liberia, according to a U.S. government health official. The Samaritan Purse aid worker, Dr Kent Brantly, returned to the United States on Saturday for medical care, and his colleague Nancy Writebol of SIM USA is due to fly back via medical aircraft on Tuesday. via Health News Headlines - Yahoo News Read More Here..
No comments:
Post a Comment